Clinical trial
MYeloma Resistance And Clonal Evolution
NCT03807128 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MYeloma Resistance And Clonal Evolution
- Lead sponsor
- Nantes University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 11, 2019
- Completion date
- February 11, 2049
- Enrollment
- 1,400 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.